Global Opioid Antagonist Market Growth 2021-2027
According to this latest study, the 2021 growth of Opioid Antagonist will have significant change from previous year. By the most conservative estimates of global Opioid Antagonist market size (most likely outcome) will be a year-over-year revenue growth rate of % in 2021, from US$ million in 2020. Over the next five years the Opioid Antagonist market will register a % CAGR in terms of revenue, the global market size will reach US$ million by 2027.
This report presents a comprehensive overview, market shares, and growth opportunities of Opioid Antagonist market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2027 in section 11.7.
Oral
Parenteral
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2027 in section 11.8.
Hospitals
Clinics
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Indivior
Alkermes
Titan Pharmaceuticals
Opiant Pharmaceuticals
Hikma Pharmaceuticals
Orexo
Camurus
Acura Pharmaceuticals
Shionogi
BioDelivery Sciences International
Collegium Pharmaceutical
AstraZeneca
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Opioid Antagonist Consumption 2016-2026
2.1.2 Opioid Antagonist Consumption CAGR by Region
2.2 Opioid Antagonist Segment by Type
2.2.1 Oral
2.2.2 Parenteral
2.3 Opioid Antagonist Sales by Type
2.3.1 Global Opioid Antagonist Sales Market Share by Type (2016-2021)
2.3.2 Global Opioid Antagonist Revenue and Market Share by Type (2016-2021)
2.3.3 Global Opioid Antagonist Sale Price by Type (2016-2021)
2.4 Opioid Antagonist Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Others
2.5 Opioid Antagonist Sales by Application
2.5.1 Global Opioid Antagonist Sale Market Share by Application (2016-2021)
2.5.2 Global Opioid Antagonist Revenue and Market Share by Application (2016-2021)
2.5.3 Global Opioid Antagonist Sale Price by Application (2016-2021)
3 Global Opioid Antagonist by Company
3.1 Global Opioid Antagonist Sales Market Share by Company
3.1.1 Global Opioid Antagonist Sales by Company (2019-2021)
3.1.2 Global Opioid Antagonist Sales Market Share by Company (2019-2021)
3.2 Global Opioid Antagonist Revenue Market Share by Company
3.2.1 Global Opioid Antagonist Revenue by Company (2019-2021)
3.2.2 Global Opioid Antagonist Revenue Market Share by Company (2019-2021)
3.3 Global Opioid Antagonist Sale Price by Company
3.4 Global Manufacturers Opioid Antagonist Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Opioid Antagonist Product Location Distribution
3.4.2 Players Opioid Antagonist Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Opioid Antagonist by Region
4.1 Global Opioid Antagonist by Region
4.1.1 Global Opioid Antagonist Sales by Region
4.1.2 Global Opioid Antagonist Revenue by Region
4.2 Americas Opioid Antagonist Sales Growth
4.3 APAC Opioid Antagonist Sales Growth
4.4 Europe Opioid Antagonist Sales Growth
4.5 Middle East & Africa Opioid Antagonist Sales Growth
5 Americas
5.1 Americas Opioid Antagonist Sales by Country
5.1.1 Americas Opioid Antagonist Sales by Country (2016-2021)
5.1.2 Americas Opioid Antagonist Revenue by Country (2016-2021)
5.2 Americas Opioid Antagonist Sales by Type
5.3 Americas Opioid Antagonist Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Opioid Antagonist Sales by Region
6.1.1 APAC Opioid Antagonist Sales by Region (2016-2021)
6.1.2 APAC Opioid Antagonist Revenue by Region (2016-2021)
6.2 APAC Opioid Antagonist Sales by Type
6.3 APAC Opioid Antagonist Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Opioid Antagonist by Country
7.1.1 Europe Opioid Antagonist Sales by Country (2016-2021)
7.1.2 Europe Opioid Antagonist Revenue by Country (2016-2021)
7.2 Europe Opioid Antagonist Sales by Type
7.3 Europe Opioid Antagonist Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Opioid Antagonist by Country
8.1.1 Middle East & Africa Opioid Antagonist Sales by Country (2016-2021)
8.1.2 Middle East & Africa Opioid Antagonist Revenue by Country (2016-2021)
8.2 Middle East & Africa Opioid Antagonist Sales by Type
8.3 Middle East & Africa Opioid Antagonist Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Opioid Antagonist Distributors
10.3 Opioid Antagonist Customer
11 Global Opioid Antagonist Market Forecast
11.1 Global Opioid Antagonist Forecast by Region
11.1.1 Global Opioid Antagonist Forecast by Regions (2021-2026)
11.2.2 Global Opioid Antagonist Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Opioid Antagonist Forecast by Type
11.7 Global Opioid Antagonist Forecast by Application
12 Key Players Analysis
12.1 Indivior
12.1.1 Indivior Company Information
12.1.2 Indivior Opioid Antagonist Product Offered
12.1.3 Indivior Opioid Antagonist Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Indivior Main Business Overview
12.1.5 Indivior Latest Developments
12.2 Alkermes
12.2.1 Alkermes Company Information
12.2.2 Alkermes Opioid Antagonist Product Offered
12.2.3 Alkermes Opioid Antagonist Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Alkermes Main Business Overview
12.2.5 Alkermes Latest Developments
12.3 Titan Pharmaceuticals
12.3.1 Titan Pharmaceuticals Company Information
12.3.2 Titan Pharmaceuticals Opioid Antagonist Product Offered
12.3.3 Titan Pharmaceuticals Opioid Antagonist Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Titan Pharmaceuticals Main Business Overview
12.3.5 Titan Pharmaceuticals Latest Developments
12.4 Opiant Pharmaceuticals
12.4.1 Opiant Pharmaceuticals Company Information
12.4.2 Opiant Pharmaceuticals Opioid Antagonist Product Offered
12.4.3 Opiant Pharmaceuticals Opioid Antagonist Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Opiant Pharmaceuticals Main Business Overview
12.4.5 Opiant Pharmaceuticals Latest Developments
12.5 Hikma Pharmaceuticals
12.5.1 Hikma Pharmaceuticals Company Information
12.5.2 Hikma Pharmaceuticals Opioid Antagonist Product Offered
12.5.3 Hikma Pharmaceuticals Opioid Antagonist Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Hikma Pharmaceuticals Main Business Overview
12.5.5 Hikma Pharmaceuticals Latest Developments
12.6 Orexo
12.6.1 Orexo Company Information
12.6.2 Orexo Opioid Antagonist Product Offered
12.6.3 Orexo Opioid Antagonist Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Orexo Main Business Overview
12.6.5 Orexo Latest Developments
12.7 Camurus
12.7.1 Camurus Company Information
12.7.2 Camurus Opioid Antagonist Product Offered
12.7.3 Camurus Opioid Antagonist Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Camurus Main Business Overview
12.7.5 Camurus Latest Developments
12.8 Acura Pharmaceuticals
12.8.1 Acura Pharmaceuticals Company Information
12.8.2 Acura Pharmaceuticals Opioid Antagonist Product Offered
12.8.3 Acura Pharmaceuticals Opioid Antagonist Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Acura Pharmaceuticals Main Business Overview
12.8.5 Acura Pharmaceuticals Latest Developments
12.9 Shionogi
12.9.1 Shionogi Company Information
12.9.2 Shionogi Opioid Antagonist Product Offered
12.9.3 Shionogi Opioid Antagonist Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Shionogi Main Business Overview
12.9.5 Shionogi Latest Developments
12.10 BioDelivery Sciences International
12.10.1 BioDelivery Sciences International Company Information
12.10.2 BioDelivery Sciences International Opioid Antagonist Product Offered
12.10.3 BioDelivery Sciences International Opioid Antagonist Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 BioDelivery Sciences International Main Business Overview
12.10.5 BioDelivery Sciences International Latest Developments
12.11 Collegium Pharmaceutical
12.11.1 Collegium Pharmaceutical Company Information
12.11.2 Collegium Pharmaceutical Opioid Antagonist Product Offered
12.11.3 Collegium Pharmaceutical Opioid Antagonist Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 Collegium Pharmaceutical Main Business Overview
12.11.5 Collegium Pharmaceutical Latest Developments
12.12 AstraZeneca
12.12.1 AstraZeneca Company Information
12.12.2 AstraZeneca Opioid Antagonist Product Offered
12.12.3 AstraZeneca Opioid Antagonist Sales, Revenue, Price and Gross Margin (2019-2021)
12.12.4 AstraZeneca Main Business Overview
12.12.5 AstraZeneca Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Opioid Antagonist Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Oral
Table 3. Major Players of Parenteral
Table 4. Global Opioid Antagonist Sales by Type (2016-2021) & (K Units)
Table 5. Global Opioid Antagonist Sales Market Share by Type (2016-2021)
Table 6. Global Opioid Antagonist Revenue by Type (2016-2021) & ($ million)
Table 7. Global Opioid Antagonist Revenue Market Share by Type (2016-2021)
Table 8. Global Opioid Antagonist Sale Price by Type (2016-2021)
Table 9. Global Opioid Antagonist Sales by Application (2016-2021) & (K Units)
Table 10. Global Opioid Antagonist Sales Market Share by Application (2016-2021)
Table 11. Global Opioid Antagonist Value by Application (2016-2021)
Table 12. Global Opioid Antagonist Revenue Market Share by Application (2016-2021)
Table 13. Global Opioid Antagonist Sale Price by Application (2016-2021)
Table 14. Global Opioid Antagonist Sales by Company (2019-2021) & (K Units)
Table 15. Global Opioid Antagonist Sales Market Share by Company (2019-2021)
Table 16. Global Opioid Antagonist Revenue by Company (2019-2021) ($ Millions)
Table 17. Global Opioid Antagonist Revenue Market Share by Company (2019-2021)
Table 18. Global Opioid Antagonist Sale Price by Company (2019-2021)
Table 19. Key Manufacturers Opioid Antagonist Producing Area Distribution and Sales Area
Table 20. Players Opioid Antagonist Products Offered
Table 21. Opioid Antagonist Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 22. New Products and Potential Entrants
Table 23. Mergers & Acquisitions, Expansion
Table 24. Global Opioid Antagonist Sales by Region (2016-2021) (K Units)
Table 25. Global Opioid Antagonist Sales Market Share by Region (2016-2021)
Table 26. Global Opioid Antagonist Revenue by Region (2016-2021) & ($ Millions)
Table 27. Global Opioid Antagonist Revenue Market Share by Region (2016-2021)
Table 28. Americas Opioid Antagonist Sales by Country (2016-2021) & (K Units)
Table 29. Americas Opioid Antagonist Sales Market Share by Country (2016-2021)
Table 30. Americas Opioid Antagonist Revenue by Country (2016-2021) & ($ Millions)
Table 31. Americas Opioid Antagonist Revenue Market Share by Country (2016-2021)
Table 32. Americas Opioid Antagonist Sales by Type (2016-2021) & (K Units)
Table 33. Americas Opioid Antagonist Sales Market Share by Type (2016-2021)
Table 34. Americas Opioid Antagonist Sales by Application (2016-2021) & (K Units)
Table 35. Americas Opioid Antagonist Sales Market Share by Application (2016-2021)
Table 36. APAC Opioid Antagonist Sales by Region (2016-2021) & (K Units)
Table 37. APAC Opioid Antagonist Sales Market Share by Region (2016-2021)
Table 38. APAC Opioid Antagonist Revenue by Region (2016-2021) & ($ Millions)
Table 39. APAC Opioid Antagonist Revenue Market Share by Region (2016-2021)
Table 40. APAC Opioid Antagonist Sales by Type (2016-2021) & (K Units)
Table 41. APAC Opioid Antagonist Sales Market Share by Type (2016-2021)
Table 42. APAC Opioid Antagonist Sales by Application (2016-2021) & (K Units)
Table 43. APAC Opioid Antagonist Sales Market Share by Application (2016-2021)
Table 44. Europe Opioid Antagonist Sales by Country (2016-2021) & (K Units)
Table 45. Europe Opioid Antagonist Sales Market Share by Country (2016-2021)
Table 46. Europe Opioid Antagonist Revenue by Country (2016-2021) & ($ Millions)
Table 47. Europe Opioid Antagonist Revenue Market Share by Country (2016-2021)
Table 48. Europe Opioid Antagonist Sales by Type (2016-2021) & (K Units)
Table 49. Europe Opioid Antagonist Sales Market Share by Type (2016-2021)
Table 50. Europe Opioid Antagonist Sales by Application (2016-2021) & (K Units)
Table 51. Europe Opioid Antagonist Sales Market Share by Application (2016-2021)
Table 52. Middle East & Africa Opioid Antagonist Sales by Country (2016-2021) & (K Units)
Table 53. Middle East & Africa Opioid Antagonist Sales Market Share by Country (2016-2021)
Table 54. Middle East & Africa Opioid Antagonist Revenue by Country (2016-2021) & ($ Millions)
Table 55. Middle East & Africa Opioid Antagonist Revenue Market Share by Country (2016-2021)
Table 56. Middle East & Africa Opioid Antagonist Sales by Type (2016-2021) & (K Units)
Table 57. Middle East & Africa Opioid Antagonist Sales Market Share by Type (2016-2021)
Table 58. Middle East & Africa Opioid Antagonist Sales by Application (2016-2021) & (K Units)
Table 59. Middle East & Africa Opioid Antagonist Sales Market Share by Application (2016-2021)
Table 60. Key and Potential Regions of Opioid Antagonist
Table 61. Key Application and Potential Industries of Opioid Antagonist
Table 62. Key Challenges of Opioid Antagonist
Table 63. Key Trends of Opioid Antagonist
Table 64. Opioid Antagonist Distributors List
Table 65. Opioid Antagonist Customer List
Table 66. Global Opioid Antagonist Sales Forecast by Region (2021-2026) & (K Units)
Table 67. Global Opioid Antagonist Consumption Market Forecast by Region
Table 68. Global Opioid Antagonist Revenue Forecast by Region (2021-2026) & ($ millions)
Table 69. Global Opioid Antagonist Revenue Market Share Forecast by Region (2021-2026)
Table 70. Americas Opioid Antagonist Sales Forecast by Country (2021-2026) & (K Units)
Table 71. Americas Opioid Antagonist Revenue Forecast by Country (2021-2026) & ($ millions)
Table 72. APAC Opioid Antagonist Sales Forecast by Region (2021-2026) & (K Units)
Table 73. APAC Opioid Antagonist Revenue Forecast by Region (2021-2026) & ($ millions)
Table 74. Europe Opioid Antagonist Sales Forecast by Country (2021-2026) & (K Units)
Table 75. Europe Opioid Antagonist Revenue Forecast by Country (2021-2026) & ($ millions)
Table 76. Middle East & Africa Opioid Antagonist Sales Forecast by Country (2021-2026) & (K Units)
Table 77. Middle East & Africa Opioid Antagonist Revenue Forecast by Country (2021-2026) & ($ millions)
Table 78. Global Opioid Antagonist Sales Forecast by Type (2021-2026) & (K Units)
Table 79. Global Opioid Antagonist Sales Market Share Forecast by Type (2021-2026)
Table 80. Global Opioid Antagonist Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 81. Global Opioid Antagonist Revenue Market Share Forecast by Type (2021-2026)
Table 82. Global Opioid Antagonist Sales Forecast by Application (2021-2026) & (K Units)
Table 83. Global Opioid Antagonist Sales Market Share Forecast by Application (2021-2026)
Table 84. Global Opioid Antagonist Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 85. Global Opioid Antagonist Revenue Market Share Forecast by Application (2021-2026)
Table 86. Indivior Basic Information, Opioid Antagonist Manufacturing Base, Sales Area and Its Competitors
Table 87. Indivior Opioid Antagonist Product Offered
Table 88. Indivior Opioid Antagonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 89. Indivior Main Business
Table 90. Indivior Latest Developments
Table 91. Alkermes Basic Information, Opioid Antagonist Manufacturing Base, Sales Area and Its Competitors
Table 92. Alkermes Opioid Antagonist Product Offered
Table 93. Alkermes Opioid Antagonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 94. Alkermes Main Business
Table 95. Alkermes Latest Developments
Table 96. Titan Pharmaceuticals Basic Information, Opioid Antagonist Manufacturing Base, Sales Area and Its Competitors
Table 97. Titan Pharmaceuticals Opioid Antagonist Product Offered
Table 98. Titan Pharmaceuticals Opioid Antagonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 99. Titan Pharmaceuticals Main Business
Table 100. Titan Pharmaceuticals Latest Developments
Table 101. Opiant Pharmaceuticals Basic Information, Opioid Antagonist Manufacturing Base, Sales Area and Its Competitors
Table 102. Opiant Pharmaceuticals Opioid Antagonist Product Offered
Table 103. Opiant Pharmaceuticals Opioid Antagonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 104. Opiant Pharmaceuticals Main Business
Table 105. Opiant Pharmaceuticals Latest Developments
Table 106. Hikma Pharmaceuticals Basic Information, Opioid Antagonist Manufacturing Base, Sales Area and Its Competitors
Table 107. Hikma Pharmaceuticals Opioid Antagonist Product Offered
Table 108. Hikma Pharmaceuticals Opioid Antagonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 109. Hikma Pharmaceuticals Main Business
Table 110. Hikma Pharmaceuticals Latest Developments
Table 111. Orexo Basic Information, Opioid Antagonist Manufacturing Base, Sales Area and Its Competitors
Table 112. Orexo Opioid Antagonist Product Offered
Table 113. Orexo Opioid Antagonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 114. Orexo Main Business
Table 115. Orexo Latest Developments
Table 116. Camurus Basic Information, Opioid Antagonist Manufacturing Base, Sales Area and Its Competitors
Table 117. Camurus Opioid Antagonist Product Offered
Table 118. Camurus Opioid Antagonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 119. Camurus Main Business
Table 120. Camurus Latest Developments
Table 121. Acura Pharmaceuticals Basic Information, Opioid Antagonist Manufacturing Base, Sales Area and Its Competitors
Table 122. Acura Pharmaceuticals Opioid Antagonist Product Offered
Table 123. Acura Pharmaceuticals Opioid Antagonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 124. Acura Pharmaceuticals Main Business
Table 125. Acura Pharmaceuticals Latest Developments
Table 126. Shionogi Basic Information, Opioid Antagonist Manufacturing Base, Sales Area and Its Competitors
Table 127. Shionogi Opioid Antagonist Product Offered
Table 128. Shionogi Opioid Antagonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 129. Shionogi Main Business
Table 130. Shionogi Latest Developments
Table 131. BioDelivery Sciences International Basic Information, Opioid Antagonist Manufacturing Base, Sales Area and Its Competitors
Table 132. BioDelivery Sciences International Opioid Antagonist Product Offered
Table 133. BioDelivery Sciences International Opioid Antagonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 134. BioDelivery Sciences International Main Business
Table 135. BioDelivery Sciences International Latest Developments
Table 136. Collegium Pharmaceutical Basic Information, Opioid Antagonist Manufacturing Base, Sales Area and Its Competitors
Table 137. Collegium Pharmaceutical Opioid Antagonist Product Offered
Table 138. Collegium Pharmaceutical Opioid Antagonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 139. Collegium Pharmaceutical Main Business
Table 140. Collegium Pharmaceutical Latest Developments
Table 141. AstraZeneca Basic Information, Opioid Antagonist Manufacturing Base, Sales Area and Its Competitors
Table 142. AstraZeneca Opioid Antagonist Product Offered
Table 143. AstraZeneca Opioid Antagonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 144. AstraZeneca Main Business
Table 145. AstraZeneca Latest Developments
List of Figures
Figure 1. Picture of Opioid Antagonist
Figure 2. Opioid Antagonist Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Opioid Antagonist Sales Growth Rate 2016-2026 (K Units)
Figure 7. Global Opioid Antagonist Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Opioid Antagonist Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Oral
Figure 10. Product Picture of Parenteral
Figure 11. Global Opioid Antagonist Sales Market Share by Type in 2020
Figure 12. Global Opioid Antagonist Revenue Market Share by Type (2016-2021)
Figure 13. Opioid Antagonist Consumed in Hospitals
Figure 14. Global Opioid Antagonist Market: Hospitals (2016-2021) & (K Units)
Figure 15. Opioid Antagonist Consumed in Clinics
Figure 16. Global Opioid Antagonist Market: Clinics (2016-2021) & (K Units)
Figure 17. Opioid Antagonist Consumed in Others
Figure 18. Global Opioid Antagonist Market: Others (2016-2021) & (K Units)
Figure 19. Global Opioid Antagonist Sales Market Share by Application (2016-2021)
Figure 20. Global Opioid Antagonist Revenue Market Share by Application in 2020
Figure 21. Opioid Antagonist Revenue Market by Company in 2020 ($ Million)
Figure 22. Global Opioid Antagonist Revenue Market Share by Company in 2020
Figure 23. Global Opioid Antagonist Sales Market Share by Regions (2016-2021)
Figure 24. Global Opioid Antagonist Revenue Market Share by Region in 2020
Figure 25. Americas Opioid Antagonist Sales 2016-2021 (K Units)
Figure 26. Americas Opioid Antagonist Revenue 2016-2021 ($ Millions)
Figure 27. APAC Opioid Antagonist Sales 2016-2021 (K Units)
Figure 28. APAC Opioid Antagonist Revenue 2016-2021 ($ Millions)
Figure 29. Europe Opioid Antagonist Sales 2016-2021 (K Units)
Figure 30. Europe Opioid Antagonist Revenue 2016-2021 ($ Millions)
Figure 31. Middle East & Africa Opioid Antagonist Sales 2016-2021 (K Units)
Figure 32. Middle East & Africa Opioid Antagonist Revenue 2016-2021 ($ Millions)
Figure 33. Americas Opioid Antagonist Sales Market Share by Country in 2020
Figure 34. Americas Opioid Antagonist Revenue Market Share by Country in 2020
Figure 35. Americas Opioid Antagonist Sales Market Share by Type in 2020
Figure 36. Americas Opioid Antagonist Sales Market Share by Application in 2020
Figure 37. United States Opioid Antagonist Revenue Growth 2016-2021 ($ Millions)
Figure 38. Canada Opioid Antagonist Revenue Growth 2016-2021 ($ Millions)
Figure 39. Mexico Opioid Antagonist Revenue Growth 2016-2021 ($ Millions)
Figure 40. Brazil Opioid Antagonist Revenue Growth 2016-2021 ($ Millions)
Figure 41. APAC Opioid Antagonist Sales Market Share by Region in 2020
Figure 42. APAC Opioid Antagonist Revenue Market Share by Regions in 2020
Figure 43. APAC Opioid Antagonist Sales Market Share by Type in 2020
Figure 44. APAC Opioid Antagonist Sales Market Share by Application in 2020
Figure 45. China Opioid Antagonist Revenue Growth 2016-2021 ($ Millions)
Figure 46. Japan Opioid Antagonist Revenue Growth 2016-2021 ($ Millions)
Figure 47. Korea Opioid Antagonist Revenue Growth 2016-2021 ($ Millions)
Figure 48. Southeast Asia Opioid Antagonist Revenue Growth 2016-2021 ($ Millions)
Figure 49. India Opioid Antagonist Revenue Growth 2016-2021 ($ Millions)
Figure 50. Australia Opioid Antagonist Revenue Growth 2016-2021 ($ Millions)
Figure 51. Europe Opioid Antagonist Sales Market Share by Country in 2020
Figure 52. Europe Opioid Antagonist Revenue Market Share by Country in 2020
Figure 53. Europe Opioid Antagonist Sales Market Share by Type in 2020
Figure 54. Europe Opioid Antagonist Sales Market Share by Application in 2020
Figure 55. Germany Opioid Antagonist Revenue Growth 2016-2021 ($ Millions)
Figure 56. France Opioid Antagonist Revenue Growth 2016-2021 ($ Millions)
Figure 57. UK Opioid Antagonist Revenue Growth 2016-2021 ($ Millions)
Figure 58. Italy Opioid Antagonist Revenue Growth 2016-2021 ($ Millions)
Figure 59. Russia Opioid Antagonist Revenue Growth 2016-2021 ($ Millions)
Figure 60. Middle East & Africa Opioid Antagonist Sales Market Share by Country in 2020
Figure 61. Middle East & Africa Opioid Antagonist Revenue Market Share by Country in 2020
Figure 62. Middle East & Africa Opioid Antagonist Sales Market Share by Type in 2020
Figure 63. Middle East & Africa Opioid Antagonist Sales Market Share by Application in 2020
Figure 64. Egypt Opioid Antagonist Revenue Growth 2016-2021 ($ Millions)
Figure 65. South Africa Opioid Antagonist Revenue Growth 2016-2021 ($ Millions)
Figure 66. Israel Opioid Antagonist Revenue Growth 2016-2021 ($ Millions)
Figure 67. Turkey Opioid Antagonist Revenue Growth 2016-2021 ($ Millions)
Figure 68. GCC Country Opioid Antagonist Revenue Growth 2016-2021 ($ Millions)
Figure 69. Channels of Distribution
Figure 70. Distributors Profiles
